Bolt Biotherapeutics Inc. Common Stock (BOLT)

About BOLT

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

23

Website

boltbio.com/

Fundamentals

1-day range

$3.86$4

Market cap

$7.65M

P/E (trailing)

—

P/E (forward)

-0.20

EPS (trailing)

$-16.34

Dividend yield

—

Beta

1.02

Avg. volume

24.4K

Forecasts

3 analyst ratings

Bolt Biotherapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• BOLT

  Bolt Biotherapeutics Inc. Common Stock

  $3.82

  ▼ 4.62%
  Market cap $7.65MP/E —
  $3.13$7.2
• MTVA

  MetaVia Inc. Common Stock

  $1.71

  ▲ 3.01%
  Market cap $7.64MP/E —
  $0.9661$19.03
• ADIL

  Adial Pharmaceuticals Inc Common Stock

  $5.6

  ▼ 1.41%
  Market cap $7.80MP/E —
  $1.31$249.81
• APRE

  Aprea Therapeutics Inc. Common stock

  $0.8387

  ▼ 2.48%
  Market cap $7.40MP/E —
  $0.548$1.69
• APUS

  Apimeds Pharmaceuticals US Inc. Common Stock

  $3.87

  ▼ 1.28%
  Market cap $7.32MP/E —
  $3.39$403.1
• TRAW

  Traws Pharma Inc. Common Stock

  $0.59

  ▲ 0.00%
  Market cap $7.18MP/E —
  $0.4301$3.27
• PCSA

  Processa Pharmaceuticals Inc. Common Stock

  $2.07

  ▼ 1.90%
  Market cap $7.09MP/E —
  $1.67$14.24

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Wednesday's Intraday Session
  Benzinga · 8/12/2026
• Bolt Biotherapeutics Q2 EPS $(4.57) Misses $(2.88) Estimate, Sales $5.000K Miss $500.000K Estimate
  Benzinga · 8/11/2026

• Berner Laura · June 10, 2026 · Grant

  5.0K
• Dupont Jakob · June 10, 2026 · Grant

  5.0K
• O'CALLAGHAN BRIAN · June 10, 2026 · Grant

  5.0K
• ONETTO NICOLE · June 10, 2026 · Grant

  5.0K
• Kathleen Laporte · June 10, 2026 · Grant

  5.0K

Institutional Ownership

March 31, 2026

Total shares held

610.1K

Total value held

$2.48M

Institutional holders

21